Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 723 for “"Multiple Myeloma"”.
-
Multiple myeloma
Not Included
-
Immunotherapy in multiple myeloma
The BDCA antibodies allowed reliable measurement of dendritic cell (DC) subsets and B cell numbers in the blood of normal subjects, and patients with MM throughout the disease course. The numbers of blood myeloid DC (BmDC) and blood plasmacytoid DC (BpDC) are low throughout the course of the …
-
Targeting Autophagy in Multiple Myeloma
Apoptosis (Type I) and autophagy (Type II) represent two major forms of programmed cell death. Numerous anticancer agents employed in standard chemotherapy or novel targeted therapy induce both apoptosis and autophagy. Of note, a cytoprotective autophagic response often counteracts apoptosis …
-
Risk Factors Associated With Multiple Myeloma
Multiple myeloma (MM) is a hematologic malignancy in which clonal plasma cells accumulate in the bone marrow, leading to the formation of lytic bone lesions, hypercalcemia, anemia, renal insufficiency, and immunosuppression. It develops from a pre-malignant condition known as monoclonal gammopathy …
-
The Role of SAMSN1 in Multiple Myeloma
Multiple myeloma (MM) is a haematological malignancy characterised by the uncontrolled clonal proliferation of neoplastic plasma cells (PCs) within the bone marrow (BM). Our group previously identified a homozygous deletion of Samsn1, a gene encoding a putative adaptor protein, in the genome of the …
-
The TAM receptor family in multiple myeloma
Multiple myeloma (MM) is a haematological malignancy of antibody secreting monoclonal plasma cells (PCs) in the bone marrow (BM). MM PC growth and survival is supported by other cells within the BM microenvironment including osteoblasts, osteoclasts, bone marrow stromal cells and immune cells. …
-
The role of TWIST1 in multiple myeloma
Multiple myeloma (MM) is an incurable haematological malignancy characterised by the uncontrolled proliferation of clonal plasma cells (PCs) in the bone marrow (BM). MM disease progression relies on the continuous trafficking of MM PCs to distant BM sites leading to multiple focal tumours …
-
The Role of Gremlin1 in Multiple Myeloma
Multiple myeloma (MM) is a fatal haematological malignancy characterised by the clonal proliferation of malignant plasma cells (PC) within the bone marrow (BM). In most instances, MM PCs are reliant on factors made by cells of the BM stroma for their survival and growth. To date, the nature and …
-
Preclinical Imaging of Multiple Myeloma Therapy Response
Multiple myeloma (MM) is a debilitating hematologic malignancy of terminally differentiated plasma cells in the bone marrow (BM). Advances in therapeutic regimens and the use of autologous stem cell transplantation have significantly improved survival rates and quality of life in patients. However, …
-
Disruption of chromosome territories in Multiple Myeloma
Background: Multiple Myeloma (MM) is an oligoclonal cancer of plasma cells. Currently, MM is an incurable disease. MM displays altered gene expression, chromosome aberrations and altered chromosome position, which contributes to high genomic instability of MM cells. Lamin A/C is a nuclear protein …
-
Cell-Free Dna Sequencing In Multiple Myeloma
<p>Multiple myeloma (MM) is an incurable plasma cell dyscrasia. Recent advances in MM therapy, including CAR-T therapy, have increased survival and shown the value of assessing treatment response with great sensitivity, both in acute and long-term settings. Cell-free DNA, DNA fragments which are …
-
An Investigation of 53BP1 in Multiple Myeloma
Currently, multiple myeloma is the second most common hematological malignancy, and as of yet it remains incurable. Although many therapeutic advances have been made in the recent past, there is still room for improvement in the treatment of myeloma. Here, using CRISPR/Cas9 genome editing, we show …
-
Investigating T Cell Exhaustion in Multiple Myeloma
Multiple Myeloma (MM) is a currently incurable malignancy of plasma cells. Immunotherapies are widely agreed upon to be the most likely avenue through which a cure could be found, however, to become longer lasting, permanent solutions, immunotherapies must overcome persistent antigenic stimulation …
-
Approaches to targeted therapy in multiple myeloma
Multiple Myeloma (MM) is the second most common hematological malignancy, and although patient outcomes have significantly improved since the introduction of autologous stem cell transplantation (ASCT) and novel pharmacological agents such as immunomodulators (IMID), proteasome inhibitors (PI), and …
-
Targeting sphingolipid metabolism proteasome inhibitor-resistant multiple myeloma
Multiple myeloma (MM) is a cancer arising from plasma cells, the cells which produce antibodies. Whilst the introduction of therapies such as proteasome inhibitors (PIs) has greatly extended life expectancy, MM is still an incurable disease as resistance regularly develops. I have developed a new …
-
Genetic changes in the development of multiple myeloma
Multiple myeloma (MM) is a malignancy of clonal plasma cells (PC) which develops as a consequence of a multistep process of transformation from a normal PC to an asymptomatic stage known as monoclonal gammopathy of undetermined significance (MGUS) to MM to the more aggressive plasma cell leukaemia …
-
ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS
Il mieloma multiplo è una neoplasia delle plasma cellule ancora incubabile, caratterizzata dall’accumulo di cellule tumorali nel midollo osseo. Durante la progressione dalla fase di Gammopatia monoclonale a significato incerto (MGUS) a mieloma multiplo diverse modifiche avvengono sia nelle plasma …
-
PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA
… that there will be more than 20,000 new cases of multiple myeloma (MM) in the US in 2011 and despite the new treatments now available, the median survival rate is only 5 years. Galectin-3C (Gal-3C) is a human lectin involved in cellular processes including cellular differentiation, apoptosis, …
Page 1 of 37